
Company profile
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
AMERICAN GENERAL FINANCE CORP, SPRINGLEAF FINANCE CORP
SEC CIK
Corporate docs
Subsidiaries
American Health and Life Insurance Company • Columbia River Funding, LLC • CommoLoCo, Inc. • CREDITHRIFT of Puerto Rico, Inc. • Fourth Avenue Auto Funding, LLC • Hubbard River Funding, LLC • Hudson River Funding, LLC • MorEquity, Inc. • Mystic River Funding, LLC • New River Funding, LLC ...
Calendar
29 Jul 22
20 Aug 22
31 Dec 22
Financial summary
Quarter (USD) | Jun 20 | Mar 20 | Sep 19 | Jun 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 19 | Dec 18 | Dec 17 | Dec 16 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Financial report summary
?Management Discussion
- Interest income remained relatively consistent in 2021 when compared to 2020 primarily due to growth in our average net finance receivables, offset by lower yield.
- Interest expense decreased $90 million or 8.8% in 2021 when compared to 2020 primarily due to a lower average cost of funds along with a decrease in average outstanding debt.
- See Notes 8 and 9 of the Notes to the Consolidated Financial Statements included in this report for further information on our long-term debt, securitization transactions, and our revolving conduit facilities.
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
auto, billed, Daruvala, exclusive, low, ordinary
Removed:
advantage, approved, economy, executed, projected, recover, strength, unprecedented
Financial reports
Current reports
8-K
Other Events
28 Apr 22
8-K
Other Events
10 Nov 21
8-K
Entry into a Material Definitive Agreement
11 Aug 21
8-K
Entry into a Material Definitive Agreement
6 Aug 21
8-K
Entry into a Material Definitive Agreement
22 Jun 21
8-K
Entry into a Material Definitive Agreement
17 Jun 21
8-K
Entry into a Material Definitive Agreement
17 Dec 20
8-K
Entry into a Material Definitive Agreement
9 Dec 20
8-K
Other Events
28 Jun 20
8-K
Entry into a Material Definitive Agreement
14 May 20
Registration and prospectus
424B7
Prospectus with selling stockholder info
12 Aug 21
424B5
Prospectus supplement for primary offering
5 Aug 21
FWP
Free writing prospectus
4 Aug 21
424B3
Prospectus supplement
4 Aug 21
424B5
Prospectus supplement for primary offering
16 Jun 21
FWP
Free writing prospectus
15 Jun 21
424B3
Prospectus supplement
15 Jun 21
424B5
Prospectus supplement for primary offering
9 Dec 20
FWP
Free writing prospectus
8 Dec 20
424B3
Prospectus supplement
8 Dec 20
Proxies
No filings
Other
CT ORDER
Confidential treatment order
8 Jun 15
EFFECT
Notice of effectiveness
7 Nov 13
UPLOAD
Letter from SEC
8 Feb 12
CORRESP
Correspondence with SEC
19 Dec 11
UPLOAD
Letter from SEC
8 Dec 11
CORRESP
Correspondence with SEC
25 Oct 11
CORRESP
Correspondence with SEC
5 Oct 11
UPLOAD
Letter from SEC
28 Sep 11
CT ORDER
Confidential treatment order
11 Aug 11
CERTNYS
Certification of approval for NYSE listing
27 Dec 09